Treatment of unruptured small and medium-sized wide necked aneurysms using the 64-wire Surpass Evolve: A subanalysis from the SEASE International Registry
Recommended Citation
Dibas M, Vivanco-Suarez J, Lopes DK, Hanel RA, Rodriguez-Calienes A, Cortez GM, Fifi JT, Devarajan A, Toth G, Patterson TE, Altschul D, Pereira VM, Liu XYE, Puri AS, Kühn AL, Guerrero WR, Khandelwal P, Bach I, Kan PT, Edhayan G, Martinez-Galdamez M, Given C, Gross BA, Narayanan S, Galecio-Castillo M, Derakhshani S, Ortega-Gutierrez S. Treatment of Unruptured Small and Medium-Sized Wide Necked Aneurysms Using the 64-Wire Surpass Evolve: A Subanalysis From the SEASE International Registry. J Am Heart Assoc. 2024 Nov 5;13(21):e036365. doi: 10.1161/JAHA.124.036365. Epub 2024 Oct 25. PMID: 39450745.
Abstract
Background: Flow diversion has revolutionized the management of wide-necked intracranial aneurysms (IAs). We aimed to assess the effectiveness and safety of the new generation 64-wire Surpass Evolve for the treatment of unruptured small/medium-sized IAs.
Methods and results: This is a subanalysis from the SEASE (Safety and Effectiveness Assessment of the Surpass Evolve) registry, an observational cohort study including 15 academic institutions in North America and Europe between July 2020 and October 2022. Patients with wide-necked saccular IAs, measuringP=0.03).
Conclusions: Patients with small/medium-sized IAs can be effectively treated using the Surpass Evolve, a new generation, 64-wire, cobalt-chromium flow diverter.
Document Type
Article
PubMed ID
39450745
Affiliations
Brain & Spine Institute, Park Ridge